Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 4,924 shares at $85.39 ($424K) on 2021-12-22, disclosed to the SEC on 2021-12-23.
Open-market sale of $424k BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.39 | 1,216 | $104K | 24.5% |
| 2 | $85.39 | 1,216 | $104K | 24.5% |
| 3 | $86.62 | 1,101 | $95K | 22.5% |
| 4 | $86.62 | 1,101 | $95K | 22.5% |
| 5 | $87.34 | 290 | $25K | 6.0% |
| Total | $86.05 avg | 4,924 |
| $424K |
| 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |